Ms. June Yan has been the CEO of NeuroFront Therapeutics since Aug. 2000. June has over 25 years of pharmaceutical industry experience in a variety of markets including China, the United States, and Asia. Before NeuroFront, June had held various leadership positions in multinational pharmaceutical companies including GM of Celgene China, VP and BU Head of Eli Lilly China, GM of Lilly Hong Kong, Marketing Director of Lilly Asia Mid-size Markets, District Sales Manager in Lilly USA, etc. June has a successful track record in building and growing organizations of different sizes and lead turn-arounds, with In-depth commercial experience spanning the entire life cycle of some of the top global brands in diverse therapeutical areas including CNS, oncology, diabetes, anti-infectious diseases, etc.
Operating Partner – Pivotal Life Sciences and Pivotal bioVenture Partners (China)